AlbuminTherapy.com | Information About Albumin Therapy

Unique Containers
FLEXBUMIN 25% [Albumin (Human)], 25% Solution is the first and only formulation of human albumin available in a flexible container. It weighs less, takes up less space, and is less likely to break than albumin stored in conventional glass containers.⁴
More >
Important Safety Information
Prescribing Information
Ask An Expert
Our experts can provide you with answers on a wide array of topics related to albumin therapy. Submit your questions today.
More >
Albumin As Excipient
Learn about human albumin's uses as an excipient. As the only global manufacturer of albumin with an FDA approved shelf life of 5 years,⁴ Baxter's albumin therapy is the logical choice.
More >

FLEXBUMIN 25% [Albumin (Human)], USP, 25% Solution

FLEXBUMIN 25% is a sterile, nonpyrogenic preparation of albumin in a single dosage form for intravenous administration. FLEXBUMIN 25% is indicated in hypovolemia, hypoalbuminemia due to inadequate production, excessive catabolism, hemorrhage, major surgery or burns, and for use during cardiopulmonary bypass surgery.

Please see FLEXBUMIN 25% [Albumin (Human)] Important Safety Information and Full Prescribing Information.

Please see BUMINATE 5% [Albumin (Human)] Important Safety Information and Full Prescribing Information.

Please see BUMINATE 25% [Albumin (Human)] Important Safety Information and Full Prescribing Information.

Gonzalez ER, Kannewurf B. The clinical use of albumin. US Pharmacist. 1998;23:HS15-HS26.
Tabor E. Plasma Protein Therapeutics Association, Brussels, Belgium. The Epidemiology of Virus Transmission by Plasma Derivatives. Transfusion. 1999; 39: 1160-1168.
FLEXBUMIN Prescribing Information. Westlake Village, CA: Baxter Healthcare Corporation; February 2006.
Data on file: Baxter Healthcare Corporation.

What is Albumin?

Unique Containers

Ask An Expert

Albumin As Excipient